HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

AbstractBACKGROUND AND PURPOSE:
Osteopontin (OPN) is neuroprotective in ischemic brain injuries in adult experimental models; therefore, we hypothesized that OPN would provide neuroprotection and improve long-term neurological function in the immature brain after hypoxic-ischemic (HI) injury.
METHODS:
HI was induced by unilateral ligation of the right carotid artery followed by hypoxia (8% O(2) for 2 hours) in postnatal Day 7 rats. OPN (0.03 μg or 0.1 μg) was injected intracerebroventricularly at 1 hour post-HI. Temporal expression of endogenous OPN was evaluated in the normal rat brain at the age of 0, 4, 7, 11, 14, and 21 days and in the ipsilateral hemisphere after HI. The effects of OPN were evaluated using 2-3-5-triphenyl tetrazolium chloride staining, apoptotic cell death assay, and cleaved caspase-3 expression. Neurological function was assessed by the Morris water maze test.
RESULTS:
Endogenous OPN expression in the brain was the highest at the age of 0 day with continuous reduction until the age of 21 days during development. After HI injury, endogenous OPN expression was increased and peaked at 48 hours. Exogenous OPN decreased infarct volume and improved neurological outcomes 7 weeks after HI injury. OPN-induced neuroprotection was blocked by an integrin antagonist.
CONCLUSIONS:
OPN-induced neuroprotection was associated with cleaved-caspase-3 inhibition and antiapoptotic cell death. OPN treatment improved long-term neurological function against neonatal HI brain injury.
AuthorsWanqiu Chen, Qingyi Ma, Hidenori Suzuki, Richard Hartman, Jiping Tang, John H Zhang
JournalStroke (Stroke) Vol. 42 Issue 3 Pg. 764-9 (Mar 2011) ISSN: 1524-4628 [Electronic] United States
PMID21273567 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Apoptosis Regulatory Proteins
  • Caspase Inhibitors
  • Osteopontin
  • Caspase 3
Topics
  • Animals
  • Animals, Newborn
  • Apoptosis (physiology)
  • Apoptosis Regulatory Proteins (administration & dosage, physiology, therapeutic use)
  • Caspase 3 (metabolism, physiology)
  • Caspase Inhibitors
  • Cell Death (drug effects, physiology)
  • Disease Models, Animal
  • Hypoxia-Ischemia, Brain (pathology, prevention & control)
  • Osteopontin (administration & dosage, physiology, therapeutic use)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: